Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
Triple-negative breast tumours (TNBTs) make up 15–20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous c...
Main Authors: | Javier Enciso-Benavides, Luis Alfaro, Carlos Castañeda-Altamirano, Nancy Rojas, José González-Cabeza, Nathaly Enciso, Fernando Riesco, Miluska Castillo, Javier Enciso |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844021013761 |
Similar Items
-
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01) -
Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
by: Maxim Olsson, et al.
Published: (2023-09-01) -
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
by: Sebastien Taurin, et al.
Published: (2020-12-01) -
Evaluation of Genistein Effect on Invasion of Breast Cancer Stem Cell-Like Cells
by: Farnaz Malekmarzban, et al.
Published: (2018-06-01) -
CD146+ Endometrial-Derived Mesenchymal Stem/Stromal Cell Subpopulation Possesses Exosomal Secretomes with Strong Immunomodulatory miRNA Attributes
by: Clarissa Leñero, et al.
Published: (2022-12-01)